Literature DB >> 20046104

In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii clinical isolates.

R Ricciardi1, A M Ricciardi, G Danzi.   

Abstract

This survey was conducted to evaluate the in vitro activity of tigecycline against 50 isolates of multidrug-resistant (MDR) Acinetobacter baumannii. Isolates of A. baumannii were resistant to ciprofloxacin, chloramphenicol, imipenem, levofloxacin, piperacillin and piperacillin-tazobactam, but were always susceptible to colistin. MICs of tigecycline were determined by E-test in Mueller-Hinton agar. The results of the study showed that 50% of the A. baumannii strains were susceptible to tigecycline.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20046104

Source DB:  PubMed          Journal:  Infez Med        ISSN： 1124-9390


  3 in total

1.  Outcomes in patients infected with carbapenem-resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy.

Authors:  R Guner; I Hasanoglu; S Keske; A K Kalem; M A Tasyaran
Journal:  Infection       Date:  2011-07-26       Impact factor: 3.553

2.  Acinetobacter Infections among Adult Patients in Qatar: A 2-Year Hospital-Based Study.

Authors:  Musaed Saad Al Samawi; Fahmi Yousef Khan; Yasser Eldeeb; Muna Almaslamani; Abdullatif Alkhal; Hussam Alsoub; Wissam Ghadban; Faraj Howady; Samar Hashim
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-06-28       Impact factor: 2.471

3.  Longitudinal Assessment of Antimicrobial Susceptibility among Gram-Negative and Gram-Positive Organisms Collected from Italy as Part of the Tigecycline Evaluation and Surveillance Trial between 2004 and 2011.

Authors:  Stefania Stefani; Michael J Dowzicky
Journal:  Pharmaceuticals (Basel)       Date:  2013-11-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.